Seattle startup HDT Bio will develop a nasal spray designed to counteract a wide range of respiratory viruses with a nearly $1.8 million grant from the U.S. Army. “We hope… Read More
Seattle vaccine company HDT Bio is seeking nearly $1 billion in a new lawsuit alleging that an India-based drugmaker stole HDT’s mRNA COVID-19 vaccine technology. The complaint, filed Monday in… Read More
Seattle-based A-Alpha Bio will support research into new therapies for COVID-19 variants in a collaboration with Lawrence Livermore National Laboratory. The partnership is powered by a $1.1 million sub-contract awarded… Read More
An experimental COVID-19 vaccine in development by Seattle-based HDT Bio will enter early-stage clinical trials in the U.S., the company announced yesterday after the U.S. Food and Drug Administration cleared… Read More
University of Washington School of Medicine researchers using a cutting-edge approach to vaccinations report that their COVID-19 vaccine is performing well in mouse and non-human primate studies. The vaccine checks… Read More